Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Dell Technologies Inc. ( DELL) Q4 2026 Earnings Call February 26, 2026 4:30 PM EST ...